5-(4-((3-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)methyl)piperazin-1-yl)-N-methylpicolinamide

ID: ALA4874589

PubChem CID: 155587004

Max Phase: Preclinical

Molecular Formula: C22H26N6O2

Molecular Weight: 406.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1cc2cnc(CN3CCN(c4ccc(C(=O)NC)nc4)CC3)cc2[nH]c1=O

Standard InChI:  InChI=1S/C22H26N6O2/c1-3-15-10-16-12-24-17(11-20(16)26-21(15)29)14-27-6-8-28(9-7-27)18-4-5-19(25-13-18)22(30)23-2/h4-5,10-13H,3,6-9,14H2,1-2H3,(H,23,30)(H,26,29)

Standard InChI Key:  KQWMSOMOYSGKJA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    5.9947   -5.1770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7111   -4.7637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7081   -3.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9929   -3.5242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2800   -4.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2842   -3.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5737   -3.5219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8546   -3.9297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8505   -4.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5655   -5.1765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1429   -3.5126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1336   -5.1650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4218   -4.7484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4210   -3.5181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1369   -3.9279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1374   -4.7545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8492   -5.1641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5645   -4.7526    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5633   -3.9267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8470   -3.5124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2763   -5.1617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2749   -5.9877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9884   -6.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7038   -5.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7012   -5.1585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9870   -4.7498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4207   -6.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4218   -7.2228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1344   -5.9846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1367   -7.6344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
  9 12  1  0
 12 13  1  0
  3 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 27 28  1  0
 27 29  2  0
 24 27  1  0
 28 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4874589

    ---

Associated Targets(Human)

PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP2 Tclin Poly [ADP-ribose] polymerase 2 (1185 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DLD-1 (17511 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.49Molecular Weight (Monoisotopic): 406.2117AlogP: 1.56#Rotatable Bonds: 5
Polar Surface Area: 94.22Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.18CX Basic pKa: 6.62CX LogP: 1.22CX LogD: 1.16
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -1.49

References

1. Sabnis RW..  (2021)  Novel Azaquinolones as PARP1 Inhibitors for Treating Cancer.,  12  (4.0): [PMID:33859786] [10.1021/acsmedchemlett.1c00122]
2. Johannes JW, Balazs A, Barratt D, Bista M, Chuba MD, Cosulich S, Critchlow SE, Degorce SL, Di Fruscia P, Edmondson SD, Embrey K, Fawell S, Ghosh A, Gill SJ, Gunnarsson A, Hande SM, Heightman TD, Hemsley P, Illuzzi G, Lane J, Larner C, Leo E, Liu L, Madin A, Martin S, McWilliams L, O'Connor MJ, Orme JP, Pachl F, Packer MJ, Pei X, Pike A, Schimpl M, She H, Staniszewska AD, Talbot V, Underwood E, Varnes JG, Xue L, Yao T, Zhang K, Zhang AX, Zheng X..  (2021)  Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs.,  64  (19.0): [PMID:34570508] [10.1021/acs.jmedchem.1c01012]

Source